JSC Dnipro Switch Factory (DnSZ, Dnipro), a major Ukrainian manufacturer of switches for main railway tracks, increased its net profit by 69.6% in January-September 2025 compared to the same period in 2024, to UAH 503.16 million.
According to the financial results report on the company’s website, net sales revenue for this period decreased by 2.7% to UAH 1 billion 542.5 million.
DnSZ received UAH 625.3 million in profit from operating activities (50% more), and gross profit amounted to UAH 657.1 million (+8.2%).
As reported, in the first half of 2025, the plant increased its net profit by 2.2 times compared to the same period in 2024, to UAH 249.2 million, with revenue growing by 24.2% to UAH 796.7 million.
Thus, in the third quarter of 2025, DnSZ increased its net profit by 39.3% compared to July-September 2024, to UAH 254 million, while net income decreased by 21%, to UAH 745.8 million.
Founded in 1916, Dnipro Railway Switch Plant currently manufactures various types of railway switches for mainline and industrial transport, subways, as well as track superstructure elements. It has a full production cycle, including its own design bureau.
The plant ended 2024 with a consolidated net profit of UAH 540.41 million, which is 6% more than in 2023, of which 78% (UAH 420 million) was allocated to dividend payments. Consolidated revenue grew by 77% to UAH 1.79 billion.
According to the company’s report on its website, unconsolidated net profit increased by 6.7% to UAH 544.22 million, with revenue growing by 31.1% to UAH 2.346 billion.
The share of exports in 2024 was 5.6%. Products were shipped to Georgia, Azerbaijan, Moldova, Bulgaria, Germany, and the Baltic states.
The aviation industry enterprise FED (Kharkiv) ended January-September 2025 with a net profit of UAH 176 million, which is 25.4% more than in the same period of 2024.
According to the company’s interim financial statements published in the NSSMC’s information disclosure system, its net income for this period increased by 32% to UAH 774.9 million.
FED received UAH 218.7 million in profit from operating activities, which is 17.3% more than last year, while gross profit increased by 30% to UAH 247.6 million.
As reported, in the first half of this year, FED JSC increased its net profit almost threefold compared to the same period in 2024, to UAH 158.2 million, with net income more than doubling to UAH 601.6 million.
Thus, in the third quarter of 2025, the company reduced its net profit by 4.8 times compared to July-September 2024, to UAH 17.8 million, while net income decreased by 42.3% to UAH 173.3 million.
FED JSC specializes in the development, production, maintenance, and repair of aviation, space, and general engineering equipment.
The average number of full-time employees as of October 1, 2025, was 953.
As reported, FED received UAH 181.4 million in net profit in 2024, which is 43% less than in 2023, of which 28% (UAH 40 million) was allocated to dividend payments. Net income decreased by 26% to UAH 831.7 million.
The pharmaceutical company PJSC Kyiv Vitamin Plant (KVP) increased its net profit by 2.2 times in the first nine months of 2025 compared to the same period in 2024, to UAH 235.185 million.
According to the company’s disclosure to the National Securities and Stock Market Commission, net sales revenue for January-September 2025 increased by 2.5% to UAH 3.529 billion.
In January-September 2025, the company produced 35.770 million packages of medicines, for a total of UAH 4.268 576 billion at list prices.
The average selling price of one package of medicines produced by KVZ was UAH 133, the average cost of a package of KVZ dietary supplements was UAH 125, and medical products were UAH 263 per package.
In addition, the company reported that in the first nine months of 2025, KVZ exported products worth UAH 123.391 million, which is 3.5% of total sales. KVZ’s main export markets are Kazakhstan, Moldova, Latvia, Uzbekistan, and Israel.
The company plans to increase sales by 17.5% in 2025.
In addition, the company reported that total research and development expenses for the third quarter of 2025 amounted to UAH 5.246 million, which is almost twice as much as in the previous quarter.
The main distributors of KVZ products are BaDM LLC, Optima-Pharm, LTD, and VENTA. LTD.
The company reports that, based on the results of the first nine months of 2025, KVZ ranked fourth in the pharmaceutical market in terms of retail sales in monetary terms, with a market share of 3.29%.
As reported, KVZ increased its net profit by 8.74% compared to 2023, to UAH 156.84 million, and its revenue from sales of goods increased by 14.71% to UAH 4.944 billion in 2024.
KVZ is one of the ten largest pharmaceutical companies in Ukraine. The company’s product portfolio includes more than 100 medicines and 20 dietary supplements.
According to the Opendatabot system, the ultimate beneficiary of KVZ is Canadian citizen Maxim Martin.
In January-September 2025, Euroins Ukraine (Kyiv) collected UAH 635.1 million in net premiums, which is 71.1% more than in the same period of 2024.
According to the company’s interim report posted on the information disclosure system of the National Securities and Stock Market Commission (NSSMC), its gross premiums for this period amounted to UAH 1.043 billion (more than 2.2 times). UAH 201.8 million was transferred to reinsurance (more than 2.4 times).
During the period, the company paid out UAH 204.9 million, which is 16.7% more than during the same period a year ago. At the same time, administrative expenses amounted to UAH 53.037 million, which is 49.2% higher than in January-September 2024.
The financial result from operating activities of IC Euroins Ukraine for nine months amounted to UAH 64.5 million, net profit – UAH 55.8 million, while a year earlier the loss amounted to UAH 10.060 million and UAH 24.439 million, respectively.
Euroins Ukraine is a universal non-life insurer that has been operating in the Ukrainian market since 1992. The company has 75 representative offices throughout the country and is licensed to provide insurance in 16 classes. It is actively involved in the segments of auto insurance, medical insurance, property insurance, liability insurance, and cargo insurance for private and corporate clients.
Euroins Ukraine Insurance Company is a member of the Motor (Transport) Insurance Bureau of Ukraine, the League of Insurance Organizations of Ukraine (LIOU), and the European Business Association (EBA).
Ilt, the official dealer of Peugeot, Citroën, DS, and Jeep car brands, earned UAH 31.07 million in net profit in January-September this year, which is 23.5% more than in the same period last year.
According to the company’s financial statements published in the NSSMC’s information disclosure system, its net income decreased by 13.2% to UAH 620.3 million.
As reported, in the first half of this year, the company increased its net profit by 55% compared to the same period in 2024, to UAH 27.3 million, while its net income decreased by 7.9%, to UAH 401 million.
Thus, in the third quarter, Ilt reduced its net profit by half compared to July-September 2024, to UAH 3.8 million, with a 21.4% decrease in revenue, to UAH 219.3 million.
The report notes that the expected income from operating lease agreements is UAH 166.3 million, and from car sales agreements – UAH 14.8 million.
The company identifies the key areas of development for the current year as increasing sales of new cars under a dealership contract with Peugeot Citroen Ukraine LLC, in particular for the DS and Citroen brands, with which it began working in 2020, and the Jeep brand, with which it has been working since 2023.
Ilt LLC began operating in Ukraine in 1992 as the official importer of Peugeot cars, and in June 2010 transferred its importer functions to Peugeot Citroën Ukraine LLC.
It is currently the official dealer in Ukraine for Stellantis car brands – Peugeot, Citroën, DS, Jeep, as well as a service dealer for Opel in Kyiv and the Kyiv region. It has two large car centers in Kyiv – Ilt on Pechersk and Ilt on Kharkivskyi, a service station, a logistics center, and spare parts warehouses.
The company mainly provides operational leasing services for passenger and commercial vehicles, as well as customer vehicle administration, sales of new and used cars, maintenance, and leases office space in its own seven-story office center, Ilt Business Center.
The report notes that in May 2025, the property complex of the subsidiary Kyiv ATP Ukrprodkontrakt was sold, which was reorganized in September by joining Ilt LLC.
As reported, in 2024, Ilt reduced its net profit by 34.8% compared to the previous year, to UAH 23.7 million, and increased its revenue by 33.5%, to UAH 915.5 million.
In January-June 2025, pharmaceutical manufacturer PJSC Monfarm (Cherkasy region) increased its net profit eightfold compared to the same period in 2024, to UAH 7.3 million.
According to the company’s disclosure to the National Securities and Stock Market Commission (NSSMC), net sales revenue for this period increased by 24.5% to UAH 133.89 million.
Monfarm PJSC was established in 1994 through the corporatization and privatization of the Monastyryshchensky Pharmaceutical Plant, a state-owned enterprise organized in 1986 on the basis of a distillery that was part of the Darnitsa Pharmaceutical Association in Kyiv.
Monfarm specializes in the production of suppositories and tableted drugs, with more than 70 names of drugs from various pharmaceutical groups.
The quality of products is confirmed by GMP certificates.
